chapter 25 Nucleotide Synthesis

Nucleotide Structure and Nomenclature

  • Nucleotides consist of three components: a nitrogenous base, a five-carbon pentose sugar (ribose in RNA, deoxyribose in DNA), and one or more phosphate groups.

  • Nitrogenous base classifications:

    • Purines: Double-ring structures comprising Adenine (AA) and Guanine (GG).

    • Pyrimidines: Single-ring structures comprising Cytosine (CC), Uracil (UU in RNA), and Thymine (TT in DNA).

  • Nomenclature:

    • RNA series: Adenine →\rightarrow Adenosine →\rightarrow Adenylate (AMP\text{AMP}); Guanine →\rightarrow Guanosine →\rightarrow Guanylate (GMP\text{GMP}); Uracil →\rightarrow Uridine →\rightarrow Uridylate (UMP\text{UMP}); Cytosine →\rightarrow Cytidine →\rightarrow Cytidylate (CMP\text{CMP}).

    • DNA series: Adenine →\rightarrow Deoxyadenosine →\rightarrow Deoxyadenylate (dAMP\text{dAMP}); Guanine →\rightarrow Deoxyguanosine →\rightarrow Deoxyguanylate (dGMP\text{dGMP}); Thymine →\rightarrow Thymidine →\rightarrow Thymidylate (TMP\text{TMP}); Cytosine →\rightarrow Deoxycytidine →\rightarrow Deoxycytidylate (dCMP\text{dCMP}).

Overview of Nucleotide Synthesis Pathways

  • De Novo Pathway: Assembles nucleotides from simple precursors, including amino acids, CO2CO_2, activated ribose (5-phosphoribosyl-1-pyrophosphate or PRPP\text{PRPP}), and ATP\text{ATP}.

  • Salvage Pathway: Recycles intact preformed bases by linking them directly to PRPP\text{PRPP}.

  • Pyrophosphatase driving force: Condensation reactions release pyrophosphate (PPi\text{PP}_i), which is cleaved by pyrophosphatase (PPi→2 Pi\text{PP}_i \rightarrow 2\,\text{P}_i), pulling reactions forward.

De Novo Pyrimidine Ribonucleotide Synthesis

  • Assembly logic: The six-membered pyrimidine ring is synthesized first as free base/intermediate and subsequently attached to ribose (PRPP\text{PRPP}) to yield Uridine 5′5^\prime-monophosphate (UMP\text{UMP}).

  • Step 1 (Carbamoyl Phosphate Synthetase II / CPS-II):

    • Catalyzes the cytosolic condensation:     HCO3−+Glutamine+2 ATP+H2O→Carbamoyl phosphate+Glutamate+2 ADP+Pi\text{HCO}_3^- + \text{Glutamine} + 2\,\text{ATP} + \text{H}_2\text{O} \rightarrow \text{Carbamoyl phosphate} + \text{Glutamate} + 2\,\text{ADP} + \text{P}_i

    • Substrate channeling: The enzyme contains three distinct catalytic centers (glutamine hydrolysis site, bicarbonate phosphorylation site, carbamic acid phosphorylation site). A molecular channel transfers intermediates directly between active sites, preventing loss and protecting labile intermediates (e.g., carbonic acid decomposes in 1 s1\,\text{s} at pH=7\text{pH} = 7).

  • Step 2 (Aspartate Transcarbamoylase / ATCase):

    • Condenses carbamoyl phosphate with aspartate to produce carbamoyl aspartate.

    • Allosteric regulation: Activated by ATP\text{ATP} (purine signal) and feedback-inhibited by CTP\text{CTP}.

    • Subunit architecture: Formed by catalytic trimers (cc chains) and regulatory dimers (rr chains containing zinc domains) shifting between active R-state and inactive T-state.

  • Mammalian CAD Complex: A multi-enzymatic polypeptide carrying the first three pathway steps: Carbamoyl phosphate synthetase, Aspartate transcarbamoylase, and Dihydroorotase.

  • Steps 4 through 6 to UMP\text{UMP}:

    • Step 4 (Dihydroorotate Dehydrogenase): Oxidizes dihydroorotate into orotate.

    • Step 5 (Orotate Phosphoribosyltransferase): Condenses orotate with PRPP\text{PRPP} to form orotidylate (OMP\text{OMP}).

    • Step 6 (Orotidylate Decarboxylase): Decarboxylates OMP\text{OMP} to form UMP\text{UMP}. Accelerates the reaction by 1017-fold10^{17}\text{-fold} (uncatalyzed reaction half-life is 78 million years78\text{ million years}).

    • Mammalian UMPS: Bifunctional enzyme Uridine Monophosphate Synthetase contains both orotate phosphoribosyltransferase and orotidylate decarboxylase activities.

Six-step pathway of de novo pyrimidine ribonucleotide synthesis from bicarbonate to UMP
  • Kinase cascades and CTP synthesis:

    • Nucleoside monophosphate kinase (specific): ATP+NMP⇌ADP+NDP\text{ATP} + \text{NMP} \rightleftharpoons \text{ADP} + \text{NDP}

    • Nucleoside diphosphate kinase: Non-specific for base or ribose vs. deoxyribose sugar:     N1DP+N2TP⇌N1TP+N2DP\text{N}_1\text{DP} + \text{N}_2\text{TP} \rightleftharpoons \text{N}_1\text{TP} + \text{N}_2\text{DP}

    • CTP Synthetase: Aminates UTP to form CTP using glutamine as an amino donor with ATP\text{ATP} consumption.

Pyrimidine Salvage Pathways and Antiviral Mechanism

  • Reversible phosphorolysis: Pyrimidine phosphorylase converts (deoxy)thymidine and Pi\text{P}_i into thymine and deoxyribose-1-phosphate.

  • Phosphorylation: Thymidine kinase transfers a phosphate to thymidine to regenerate TMP\text{TMP}.

  • Acyclovir antiviral activation:

    • Herpes Simplex Virus (HSV) thymidine kinase phosphorylates acyclovir to acyclovir phosphate.

    • Host cell kinases further convert acyclovir phosphate into acyclovir triphosphate.

    • Incorporated into viral DNA, competitively halting viral DNA polymerase and terminating viral DNA chain elongation.

De Novo Purine Ribonucleotide Synthesis

  • Assembly logic: The purine ring is assembled step-by-step directly upon a pre-formed ribose platform (PRPP\text{PRPP}).

  • Synthesis of PRPP\text{PRPP}:   Ribose 5-phosphate+ATP→PRPP+AMP\text{Ribose 5-phosphate} + \text{ATP} \rightarrow \text{PRPP} + \text{AMP}

  • Committed step: Catalyzed by glutamine phosphoribosyl amidotransferase:   PRPP+Glutamine+H2O→5-Phosphoribosyl 1-amine+Glutamate+PPi\text{PRPP} + \text{Glutamine} + \text{H}_2\text{O} \rightarrow \text{5-Phosphoribosyl 1-amine} + \text{Glutamate} + \text{PP}_i

  • Purine ring origins:

    • N1N_1: Aspartate

    • C2,C8C_2, C_8: N10-Formyl-tetrahydrofolateN^{10}\text{-Formyl-tetrahydrofolate}

    • N3,N9N_3, N_9: Glutamine

    • C4,C5,N7C_4, C_5, N_7: Glycine

    • C6C_6: CO2CO_2

Sources of atoms in the purine ring structure and overview to IMP
  • Multi-enzyme complexes to Inosine Monophosphate (IMP):

    • Trifunctional TrifGART: Glycinamide ribonucleotide synthetase (GARS), GAR transformylase (GAR Tfase), Aminoimidazole ribonucleotide synthetase (AIRS).

    • Bifunctional PAICS: Carboxyaminoimidazole ribonucleotide synthase (CAIRS), Succinylaminoimidazole carboxamide ribonucleotide synthetase (SAICARS).

    • Bifunctional ATIC: Aminoimidazole carboxamide ribonucleotide transformylase (AICAR Tfase), IMP cyclohydrolase (IMPCH).

Conversion of IMP to AMP and GMP

  • Synthesis of AMP from IMP:

    • Step 1: Adenylosuccinate synthetase condenses aspartate with IMP using GTP\text{GTP} hydrolysis.

    • Step 2: Adenylosuccinate lyase eliminates fumarate, leaving AMP\text{AMP}.

  • Synthesis of GMP from IMP:

    • Step 1: IMP dehydrogenase oxidizes IMP to xanthosine monophosphate (XMP\text{XMP}) with NAD+\text{NAD}^+ reduction.

    • Step 2: GMP synthetase transfers an amino group from glutamine to XMP\text{XMP} driven by ATP\text{ATP} hydrolysis.

  • Cross-regulation: AMP synthesis requires GTP\text{GTP}, whereas GMP synthesis requires ATP\text{ATP}, ensuring balanced purine production.

Branched pathway for the conversion of IMP to AMP and GMP

Purine Salvage Pathways

  • Adenine Phosphoribosyltransferase (APRT):   Adenine+PRPP→AMP+PPi\text{Adenine} + \text{PRPP} \rightarrow \text{AMP} + \text{PP}_i

  • Hypoxanthine-Guanine Phosphoribosyltransferase (HGPRT):

    • Salvages hypoxanthine:     Hypoxanthine+PRPP⇌IMP+PPi\text{Hypoxanthine} + \text{PRPP} \rightleftharpoons \text{IMP} + \text{PP}_i

    • Salvages guanine:     Guanine+PRPP⇌GMP+PPi\text{Guanine} + \text{PRPP} \rightleftharpoons \text{GMP} + \text{PP}_i